1. Home
  2. CRMD vs VERB Comparison

CRMD vs VERB Comparison

Compare CRMD & VERB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRMD
  • VERB
  • Stock Information
  • Founded
  • CRMD 2006
  • VERB 2014
  • Country
  • CRMD United States
  • VERB United States
  • Employees
  • CRMD N/A
  • VERB 23
  • Industry
  • CRMD Biotechnology: Pharmaceutical Preparations
  • VERB Other Consumer Services
  • Sector
  • CRMD Health Care
  • VERB Consumer Discretionary
  • Exchange
  • CRMD Nasdaq
  • VERB Nasdaq
  • Market Cap
  • CRMD 925.6M
  • VERB 877.8M
  • IPO Year
  • CRMD 2010
  • VERB N/A
  • Fundamental
  • Price
  • CRMD $13.09
  • VERB $8.26
  • Analyst Decision
  • CRMD Strong Buy
  • VERB Strong Buy
  • Analyst Count
  • CRMD 8
  • VERB 1
  • Target Price
  • CRMD $17.57
  • VERB $62.00
  • AVG Volume (30 Days)
  • CRMD 4.6M
  • VERB 2.1M
  • Earning Date
  • CRMD 10-29-2025
  • VERB 08-06-2025
  • Dividend Yield
  • CRMD N/A
  • VERB N/A
  • EPS Growth
  • CRMD N/A
  • VERB N/A
  • EPS
  • CRMD 0.79
  • VERB N/A
  • Revenue
  • CRMD $121,484,498.00
  • VERB $4,279,000.00
  • Revenue This Year
  • CRMD $404.81
  • VERB $526.82
  • Revenue Next Year
  • CRMD $56.11
  • VERB $45.45
  • P/E Ratio
  • CRMD $16.53
  • VERB N/A
  • Revenue Growth
  • CRMD 14970.29
  • VERB 4095.10
  • 52 Week Low
  • CRMD $5.60
  • VERB $3.81
  • 52 Week High
  • CRMD $17.43
  • VERB $29.77
  • Technical
  • Relative Strength Index (RSI)
  • CRMD 51.16
  • VERB 31.19
  • Support Level
  • CRMD $12.73
  • VERB $9.58
  • Resistance Level
  • CRMD $13.83
  • VERB $21.78
  • Average True Range (ATR)
  • CRMD 0.78
  • VERB 1.67
  • MACD
  • CRMD -0.16
  • VERB -1.37
  • Stochastic Oscillator
  • CRMD 44.67
  • VERB 1.89

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

About VERB Verb Technology Company Inc.

Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.

Share on Social Networks: